SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD

Review checklist: John F. Kennedy (HR-ML023)
All records · Back to the record · Dossier (sources.md) · Terminology · Report a problem · Comments
Everything a reviewer needs to judge, gathered from the record. Release status: draft.
- 11judgment calls in the dossier
- 1protocol deviations
- 0orders and referrals without results in the record
- 10evidence items to check (retrospective or sensitive claims, unconfirmed diagnoses)
Review status
| Review | Status | Reviewer | Date | Notes |
|---|
| schema validation | not_started | | | Run scripts/build.ps1 -Conformance. |
| clinical review | not_started | | | Awaiting clinician review; check the hydrocortisone and fludrocortisone doses and their adjustment, the sick-day rules, levothyroxine started only after glucocorticoid replacement was secure, the DXA indication at 30, and the back pain plan. |
| provenance review | not_started | | | Miller Center pages, two History.com articles, Time, PBS NewsHour, CNN Wire, Healio, the Associated Press, and four PubMed abstracts logged. The Atlantic article and the JFK Library pages could not be fetched (access blocked) and are not cited directly; Dallek's findings are cited as Time, History.com and CNN report them. |
| safe messaging review | not_started | | | Claims about medicines he received (procaine injections and the medicines Dallek lists) and the retrospective autoimmune interpretations are marked sensitive. No drug beyond those named in the sources is mentioned. His death is recorded as history in one sentence. |
Judgment calls (dossier editorial resolutions)
- Recent-death rule. Kennedy died in 1963, so the rule does not apply. Every historical claim is limited to what the fetched sources state. Claims about medicines he received (CLM-0017, the procaine injections; CLM-0019, Dallek’s list) and the retrospective autoimmune interpretations (CLM-0016, CLM-0022, CLM-0023) are marked sensitive. Reports of amphetamine injections from another physician, and of other named drugs (including those in the History.com list), are not used; no drug beyond those in CLM-0013, CLM-0014, CLM-0016, CLM-0017 and CLM-0019 is mentioned. His death is recorded in one sentence (CLM-0021) and not used in the modern episode.
- Sources that could not be read. Robert Dallek’s article in The Atlantic (December 2002) blocked automated access, and the JFK Library pages returned “forbidden”; neither is cited directly. Dallek’s findings are cited only as Time, History.com, and CNN report them, and the 2009 and 2017 articles only through their PubMed abstracts and press reports. The physician who made the 1947 diagnosis in England, the city, the month of the collapse, and the name of the Boston endocrinologist were not confirmed by a fetched source and are not used.
- Index age and dates. The index visit on January 12, 2026 maps to January 12, 1948, when he was 30, after the documented 1947 diagnosis (month not documented in the fetched sources) and his return to Boston. The synthetic date of birth is May 29, 1995 (shift 78 years). The chronic-care visits on January 26, March 9, April 20, and October 19, 2026, the sick visit on February 16, 2026, and the preventive visit on August 17, 2026 map to the same days of 1948, when he was a first-term congressman; they are a modern teaching episode, not a claim about where he was. The hospital start of hydrocortisone and fludrocortisone on October 6, 2025 (true frame October 6, 1947) stands for treatment begun at the diagnosis. Past medical history includes only events before the index date; claims about later events (cortisone, the 1954 and 1955 operations, hypothyroidism, procaine, the 1960 denial, the presidency, and the retrospective reviews that rely on them) are linked only to later timeline events, so the intake documents do not show them.
- Problems. Primary adrenal insufficiency is E27.1, linked to the documented diagnosis. The back pain is coded M96.1 (postlaminectomy syndrome) because it persisted after his 1944 lumbar operation; no bone disease is coded, because the retrospective reviews disagree (CLM-0024, R, disputed) and the synthetic DXA is within the expected range. The raised TSH found on autoimmune screening at intake is its own problem (R94.6), resolved at the six-week visit, when autoimmune hypothyroidism (E06.3) is recorded after the confirmatory repeat. This mirrors his documented later hypothyroidism (CLM-0016) and Mandel’s interpretation (CLM-0022) but is placed in the modern episode as screening, as the guideline advises for anyone with this diagnosis. Celiac serology is negative, so the retrospective celiac hypothesis (CLM-0023, R, possible) is not turned into a diagnosis. Influenza A (J10.1) is added at the sick visit and resolved at six weeks. No F-code or positive depression screen is present, so no safety assessment is required.
- Treatment choices. The modern episode uses hydrocortisone and fludrocortisone, not the DOCA pellets and cortisone he actually received, and it does not reproduce any of his documented treatments for back pain. The discharge dose of 30 mg hydrocortisone a day is reduced to 20 mg in three doses on the consultant’s advice; fludrocortisone is raised from 0.05 to 0.1 mg because of a raised renin, low sodium, high potassium, and a postural drop; levothyroxine is started only after the raised TSH is confirmed and glucocorticoid replacement is secure.
- Real people. Robert Dallek, Lee Mandel, Jeffrey Kelman, Pait and Dowdy, Pinals and Hassett, Macchia and colleagues, Dr. Janet Travell and Dr. Hans Kraus appear only in the claims and sources. No modern decision, statement, or health fact is attributed to any real person; no relative is named, and no family history is recorded. His wish to decide who is told is synthetic, anchored to his documented concealment of the diagnosis.
- Synthetic content. All visits, laboratory values, vital signs, the DXA, survey scores, the hospital admission abroad, the discharge letter, the medicines and doses, the emergency kit, the influenza, his height (183 cm) and weights, his household and work routine, and the health care agent are synthetic. Qualitative results (influenza test, HIV and hepatitis C screening) appear only in the note text.
- Preventive visit. A periodic adult preventive visit at 31 (CPT 99395 with 99497 in plain text). Judgment calls: Tdap because no booster is recorded within ten years; hepatitis B vaccination for an adult under 60 with no record; HPV vaccine offered by shared decision-making and declined; diabetes screening up to date because of the A1c done for autoimmune screening; advance care planning limited to his own general preferences and an emergency hydrocortisone letter, with an unnamed agent.
- Sick visit. Influenza A five weeks after his influenza vaccine, chosen because a febrile illness is the commonest reason for stress dosing. It teaches the sick-day rules (double for fever above 38 °C, triple above 39 °C, inject and call 911 for vomiting or collapse), checking for adrenal crisis (postural blood pressure, sodium, potassium, glucose), and oseltamivir for a person at higher risk. It implies no real diagnosis.
- Focused visits. The four chronic-care follow-ups (two weeks with the consultation, six weeks, twelve weeks, and nine months) are documented as focused visits on the Endocrine Society 2016 guideline, the CMID hypothyroidism monograph with the ATA 2014 guideline, the ACP 2017 low back pain guideline, and the ACR 2022 and Endocrine Society bone guidance. One deviation is recorded instead of an invented result: at the twelve-week visit blood pressure was taken seated only, not lying and standing; no harm resulted (no symptoms, normal sodium and potassium, and no postural drop at the next measurement), and postural blood pressure was added to the visit template. The bone density scan is not repeated, with the reason recorded; vitamin B12, A1c and celiac serology are due at one year, after the episode ends.
- Consultation. The endocrinology referral and the consultation by Mira Desai, MD (a fictional consultant), on the day of the two-week visit, are S. The consultant answers the six referral questions in line with what the record shows afterwards: no further diagnostic tests, hydrocortisone reduced to 20 mg a day, fludrocortisone raised to 0.1 mg with renin normal six weeks later, the TSH confirmed before levothyroxine was started at six weeks, no bone-protective medicine and no repeat scan, the sick-day rules he then used correctly in influenza, and yearly endocrinology review and autoimmune screening.
Protocol deviations
Checks the monitoring protocol called for that the schedule did not perform. Each is recorded with its outcome and corrective action, never filled with an invented result.
| Visit | Measure | Interval | What happened |
|---|
2026-04-20 Progress note 05 (C-CDA) | Blood pressure lying and standing | Every visit | Missed: only a seated blood pressure (120/76) was taken. No harm resulted: he had no lightheadedness, sodium and potassium were normal, and there was no postural drop when it was next measured at the preventive visit. Corrective action: lying and standing blood pressure added to the visit template for adrenal insufficiency |
Orders and referrals without results in the record
None.
Evidence to check
Retrospective claims (R)
| Claim | Statement | Certainty |
|---|
| CLM-0005 | The historian Robert Dallek, who examined his medical records at the Kennedy Library, believed that many of his difficulties could be traced to corticosteroids taken perhaps as early as 1937 to relieve his colitis, noting that heavy long-term use can promote osteoporosis. | possible |
| CLM-0022 | Reviewing his medical records in 2009, Lee Mandel concluded that his Addison's disease and his hypothyroidism were most likely parts of a single autoimmune disorder, autoimmune polyglandular syndrome type 2. | probable |
| CLM-0023 | Macchia and colleagues proposed that his bowel symptoms from adolescence fit well with coeliac disease. | possible |
| CLM-0024 | Retrospective reviews of his back disagree. The physician who reviewed the records with Dallek said he had compression fractures in his low back and osteoporosis; Pait and Dowdy, reviewing his X-rays, found no sign of underlying bone disease or of a steroid-related fracture and judged that his four back operations (a discectomy, a fusion with instrumentation, and two smaller operations) failed to relieve his pain. | disputed |
| CLM-0025 | Pinals and Hassett argued in 2013 that, because operations on the presumed structural cause brought little relief and a conservative program with trigger point injections and exercise helped modestly, his pain is better understood through current pain research than as a purely structural problem. | possible |
Sensitive claims
| Claim | Grade | Statement |
|---|
| CLM-0016 | D | He was diagnosed with hypothyroidism during a hospital stay in New York in 1955, and he is reported to have taken liothyronine throughout his presidency. |
| CLM-0017 | D | Dr. Janet Travell, who first saw him in May 1955 and later became his White House physician, treated his back with injections of procaine into the muscles; Pait and Dowdy write that he received hundreds, if not thousands, of injections over about four years, which with muscle strengthening and the corset brought marked improvement. |
| CLM-0019 | D | Dallek reported that during his presidency he took many medicines each day: steroids for his Addison's disease, painkillers for his back, antispasmodics for his colitis, antibiotics for urinary tract infections, and antihistamines for allergies. |
| CLM-0022 | R | Reviewing his medical records in 2009, Lee Mandel concluded that his Addison's disease and his hypothyroidism were most likely parts of a single autoimmune disorder, autoimmune polyglandular syndrome type 2. |
| CLM-0023 | R | Macchia and colleagues proposed that his bowel symptoms from adolescence fit well with coeliac disease. |
Diagnoses not confirmed
None.
Notes to read
Every note in the record, with its type. All clinical content is synthetic.
Abnormal results
| Date | Result | Value | Flag |
|---|
| 2026-01-12 | Sodium | 134 mmol/L (low) | Low |
| 2026-01-12 | Potassium | 5.2 mmol/L (high) | High |
| 2026-01-12 | Plasma renin activity | 9.6 ng/mL/h (high) | High |
| 2026-01-12 | 21-hydroxylase antibodies | 18 U/mL (high) | High |
| 2026-01-12 | TSH | 7.4 mIU/L (high) | High |
| 2026-01-12 | Thyroid peroxidase antibodies | 286 [IU]/mL (high) | High |
| 2026-03-09 | TSH | 9.2 mIU/L (high) | High |